Daniel Patrick O'Day - 10 Dec 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Issuer symbol
GILD
Transactions as of
10 Dec 2025
Net transactions value
-$598,328
Form type
4
Filing time
11 Dec 2025, 20:38:48 UTC
Previous filing
01 Dec 2025
Next filing
30 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Day Daniel Patrick Chairman & CEO, Director 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Daniel P. O'Day 11 Dec 2025 0001638643

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +10,426 +1.8% 581,629 10 Dec 2025 Direct F1
transaction GILD Common Stock Tax liability $598,328 -4,931 -0.85% $121.34 576,698 10 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -10,426 -11% 88,070 10 Dec 2025 Common Stock 10,426 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.